• OPEN AN ACCOUNT
Indian Indices
Nifty
25,879.15 3.35
(0.01%)
Sensex
84,478.67 12.16
( 0.01%)
Bank Nifty
58,381.95 107.30
( 0.18%)
Nifty IT
36,679.50 -175.90
( -0.48%)
Global Indices
Nasdaq
48,279.16 330.20
(0.69%)
Dow Jones
6,872.70 5.09
(0.07%)
Hang Seng
51,206.70 143.39
(0.28%)
Nikkei 225
9,910.49 10.89
(0.11%)
Forex
USD-INR
88.68 0.06
(0.07%)
EUR-INR
102.52 0.03
(0.03%)
GBP-INR
116.74 0.13
(0.11%)
JPY-INR
0.58 0.00
(-0.30%)

EQUITY - MARKET SCREENER

Gufic BioSciences Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
509079
INE742B01025
59.9565319
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GUFICBIO
54.19
3314.84
EPS(TTM)
Face Value()
Div & Yield %
6.1
1
0.03
 

rnit ai solutions ltd
Praveg reports consolidated net loss of Rs 6.14 crore in the June 2025 quarter
Aug 14,2025
Net loss of Praveg reported to Rs 6.14 crore in the quarter ended June 2025 as against net profit of Rs 0.76 crore during the previous quarter ended June 2024. Sales rose 68.33% to Rs 39.39 crore in the quarter ended June 2025 as against Rs 23.40 crore during the previous quarter ended June 2024.

ParticularsQuarter Ended
Jun. 2025Jun. 2024% Var.
Sales39.3923.40 68
OPM %14.6027.05 -
PBDT3.995.98 -33
PBT-5.441.02 PL
NP-6.140.76 PL